|
| SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea Basic information |
Product Name: | SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea | Synonyms: | SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea;1-benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea;CS-2536;SRI-011381 HCL;Urea, N'-cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-;Transforming growth factor beta,SRI011381,inhibit,multiple,neuroprotective,NALP3,collagen-1,SRI-011381,SRI 011381,TGF-β,sclerosis,Inhibitor,α-SMA,TGF-beta/Smad | CAS: | 1629138-41-5 | MF: | C20H31N3O | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | 1629138-41-5.mol | |
| SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea Chemical Properties |
storage temp. | Store at -20°C | solubility | DMF: 15 mg/ml; DMSO: 20 mg/ml; Ethanol: 25 mg/ml; Ethanol:PBS (pH 7.2) (1:4): 0.2 mg/ml | form | A crystalline solid |
| SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea Usage And Synthesis |
Uses | SRI-011381 is a novel agonist of the TGF-beta signaling pathway for treatment of Alzheimer''s disease. |
| SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea Preparation Products And Raw materials |
|